SP
ELV icon

Symmetry Partners’s Elevance Health ELV Stock Holding History

Symmetry Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-393
Closed -$204K – 132
2024
Q3 		$204K Sell
393
-2,689
-87% -$1.44M 0.05% 83
2024
Q2 		$1.67M Sell
3,082
-117
-4% -$61.8K 0.09% 100
2024
Q1 		$1.66M Hold
3,199
– – 0.13% 107
2023
Q4 		$1.5M Sell
3,199
-344
-10% -$159K 0.08% 111
2023
Q3 		$1.54M Sell
3,543
-588
-14% -$267K 0.08% 118
2023
Q2 		$1.83M Sell
4,131
-524
-11% -$242K 0.1% 102
2023
Q1 		$2.14M Buy
4,655
+464
+11% +$221K 0.12% 96
2022
Q4 		$2.15M Sell
4,191
-403
-9% -$205K 0.13% 88
2022
Q3 		$2.09M Hold
4,594
– – 0.14% 85
2022
Q2 		$2.22M Sell
4,594
-275
-6% -$136K 0.15% 75
2022
Q1 		$2.39M Buy
4,869
+778
+19% +$356K 0.15% 80
2021
Q4 		$1.9M Hold
4,091
– – 0.12% 115
2021
Q3 		$1.53M Sell
4,091
-701
-15% -$266K 0.1% 134
2021
Q2 		$1.83M Hold
4,792
– – 0.12% 109
2021
Q1 		$1.72M Sell
4,792
-944
-16% -$304K 0.12% 111
2020
Q4 		$1.84M Buy
5,736
+1,009
+21% +$310K 0.14% 95
2020
Q3 		$1.27M Buy
4,727
+2,807
+146% +$755K 0.11% 121
2020
Q2 		$505K Buy
+1,920
New +$512K 0.06% 150
2019
Q4 		– Sell
-3,997
Closed -$960K – 337
2019
Q3 		$960K Sell
3,997
-368
-8% -$101K 0.2% 66
2019
Q2 		$1.23M Hold
4,365
– – 0.25% 58
2019
Q1 		$1.25M Buy
4,365
+326
+8% +$94.3K 0.21% 63
2018
Q4 		$1.06M Buy
+4,039
New +$1.11M 0.27% 55

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Symmetry Partners's ELV Position: Q4 2024 in Review

Symmetry Partners sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 393 shares — an estimated $204K sold.

Symmetry Partners first reported a position in ELV in Q4 2018 and held it in 22 quarters. The position peaked at $2.39M in Q1 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Symmetry Partners reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Symmetry Partners sold 393 Elevance Health shares in Q4 2024, an estimated $204K.
  • Symmetry Partners first reported a position in Elevance Health in Q4 2018 and held it in 22 quarters.
  • Symmetry Partners's Elevance Health position peaked at $2.39M in Q1 2022.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Symmetry Partners's 13F filing for Q4 2024, filed 11 Feb 2025.